Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04271410
What this trial is testing

CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma

Who this might be right for
LeukemiaLymphoma, Large B-Cell, DiffuseLeukemia, B-cell+2 more
Chongqing Precision Biotech Co., Ltd 80
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Early research (Phase 1)Study completedNCT00562224
What this trial is testing

Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients

Who this might be right for
Neoplasms by SiteLymphoma, Non-hodgkinHodgkin Disease+2 more
Pharmacyclics LLC. 36
Early research (Phase 1)Ended earlyNCT03893682
What this trial is testing

CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNon-Hodgkin's Lymphoma
Aptose Biosciences Inc. 36
Early research (Phase 1)Study completedNCT02296918
What this trial is testing

Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaProlymphocytic Leukemia
Acerta Pharma BV 69
Testing effectiveness (Phase 2)WithdrawnNCT01138579
What this trial is testing

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

Who this might be right for
LeukemiaStem Cell Transplantation
Technical University of Munich
Early research (Phase 1)Study completedNCT00078520
What this trial is testing

Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells

Who this might be right for
LeukemiaLeukemia, B-Cell, Chronic
Baylor College of Medicine 9
Early research (Phase 1)Active Not RecruitingNCT02157324
What this trial is testing

Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Acerta Pharma BV 12
Testing effectiveness (Phase 2)Study completedNCT00481091
What this trial is testing

ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT00201682
What this trial is testing

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
John Byrd 36
Testing effectiveness (Phase 2)Study completedNCT01572662
What this trial is testing

Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

Who this might be right for
LeukemiaAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+7 more
M.D. Anderson Cancer Center 201
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00038025
What this trial is testing

Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell LymphomaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT01500733
What this trial is testing

PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLeukemia, LymphocytycCLL (Chronic Lymphocytic Leukemia)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 86
Not applicableUnknownNCT03150849
What this trial is testing

C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Assiut University 50
Not applicableStudy completedNCT03545035
What this trial is testing

Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 104
Testing effectiveness (Phase 2)UnknownNCT05287984
What this trial is testing

Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNewly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China 63
Early research (Phase 1)Study completedNCT01527838
What this trial is testing

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Hodgkin's DiseaseChronic Lymphocytic Leukemia (CLL)+2 more
Fate Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Next Page